Acquisition by Growth Equity Opportunities 17, Llc of 333333 shares of Savara at 3.0 subject to Rule 16b-3
SVRA Stock | USD 3.36 0.20 5.62% |
About 62% of Savara's investor base is looking to short. The analysis of the overall investor sentiment regarding Savara Inc suggests that many traders are alarmed. The current market sentiment, together with Savara's historical and current headlines, can help investors time the market. In addition, many technical investors use Savara Inc stock news signals to limit their universe of possible portfolio assets.
Savara |
Filed transaction by Savara Inc 10 Percent Owner. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Savara's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Savara's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Savara Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Savara can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Savara Fundamental Analysis
We analyze Savara's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Savara using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Savara based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Savara is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Savara Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Savara stock to make a market-neutral strategy. Peer analysis of Savara could also be used in its relative valuation, which is a method of valuing Savara by comparing valuation metrics with similar companies.
Peers
Savara Related Equities
PTIX | Protagenic Therapeutics | 5.77 | ||||
KZR | Kezar Life | 2.21 | ||||
IKNA | Ikena Oncology | 1.80 | ||||
FENC | Fennec Pharmaceuticals | 1.32 | ||||
CRNX | Crinetics Pharmaceuticals | 0.97 | ||||
ANAB | AnaptysBio | 0.92 | ||||
RVMD | Revolution Medicines | 0.53 | ||||
GPCR | Structure Therapeutics | 0.06 | ||||
XOMAO | XOMA | 0.39 | ||||
ACLX | Arcellx | 0.82 | ||||
XLO | Xilio Development | 0.93 | ||||
DYN | Dyne Therapeutics | 1.19 | ||||
RZLT | Rezolute | 1.39 | ||||
SRRK | Scholar Rock | 2.11 | ||||
TPST | Tempest Therapeutics | 2.20 | ||||
AVTE | Aerovate Therapeutics | 2.23 | ||||
EWTX | Edgewise Therapeutics | 2.58 | ||||
XOMA | XOMA Corp | 2.71 | ||||
STOK | Stoke Therapeutics | 3.63 | ||||
TRDA | Entrada Therapeutics | 4.69 | ||||
TARA | Protara Therapeutics | 6.30 | ||||
ALXO | Alx Oncology | 8.14 |
Complementary Tools for Savara Stock analysis
When running Savara's price analysis, check to measure Savara's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Savara is operating at the current time. Most of Savara's value examination focuses on studying past and present price action to predict the probability of Savara's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Savara's price. Additionally, you may evaluate how the addition of Savara to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Stocks Directory Find actively traded stocks across global markets |